UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 1, 2021
Accession Number:
0001493152-21-030102
Submission Type:
POS AM
CIK:
0001857044
Company Name:
Indaptus Therapeutics, Inc.
File Number:
333-230016